Analgesics is expected to register moderate constant value growth in 2023. In spite of continuing very high inflation, volume growth is also expected to be healthy, and is supported by continuing population growth. Price limits on analgesics is also protecting consumers, but it is putting a lot of pressure on companies’ profitability. As such, GSK Consumer Healthcare announced that it was going to pull out. In response, the government permitted a 25% increase in paracetamol prices.
The Analgesics in Pakistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Analgesics in Pakistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market
- Pinpoint growth sectors and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
ANALGESICS IN PAKISTANKEY DATA FINDINGSCONSUMER HEALTH IN PAKISTANDISCLAIMERDEFINITIONS
2023 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
